Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

收购交易核心条款 - 澳大利亚Telix Pharmaceuticals同意以约16.5亿美元(现金及无负债基准)收购德国ITM Isotope Technologies Munich SE [1] - 经调整后,ITM股东预计将获得约12.5亿美元的Telix股份,每股作价11.84美元 [1]

Telix Pharmaceuticals Ltd-Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion - Reportify